 |
 |
Research in applied genomics to drugs and diagnostics |
New
awards
February 2004 |
The TDR Working Group on and Applied Genomics to Drugs and Diagnostics [workplan],
established by the Committee on Pathogenesis and Applied Genomics [workplan],
met in Boston, Massachusetts, USA in October 2003, to deliberate and
recommend projects for funding by TDR. The projects listed below were
selected from among a large number of applications received from
investigators worldwide. The grants will be funded for one year only as pilot
projects.
New grants in genome to
drugs and diagnostics
These grants will be funded for one year
in the first instance, and for an additional year if sufficient progress
is made in the first year toward reaching the scientific objectives, and
if sufficient funds are available.
Project
ID |
Principal
Investigator |
Institution |
|
Project
Title |
Funding
in US$ |
|
A30496 |
Dr Manoj Duraisingh |
Harvard School of Public Health,
Boston, USA |
|
A forward genetics approach for
identifying molecular determinants to quinoline in P.
falciparum |
40,000 |
|
A30526 |
Dr Qian Gao |
Fudan University, Shanghai
Medical College, China |
|
Identification of potential new
drug targets of M. tuberculosis using comparative gene
expression analysis |
23,300 |
|
A30462 |
Dr Tanya Parish |
Queen Mary's of Medicine and
Dentistry, Barts and the London, United Kingdom |
|
High throughput directed
mutagenesis in the Mycobacterium tuberculosis complex |
24,000 |
|
A30535 |
Dr Philip Suffys |
Oswaldo Cruz Foundation, FIOCRUZ,
Rio de Janeiro, Brazil |
|
Evaluation of variability and
stability of small variable number tandem repeats in M. leprae
for possible strain typing |
29,500 |
TDR expresses sincere gratitude to
members of the Working Group and to external reviewers for their
critical assessment and contributions to the selection process.
A large number of projects were
reviewed but only a few selected due to the highly competitive selection
process. TDR would like to encourage those investigators who were not
successful this time to continue their
good work and to re-compete for funding next year (see deadline
for submission of new applications).
TDR Contact: Dr
Oduola
|
